Borzomed Bortezomib 3.5 mg Injection
Borzomed Bortezomib 3.5 mg Injection is an anti-cancer medication used in the treatment of multiple myeloma and mantle cell lymphoma. It contains Bortezomib, a proteasome inhibitor that works by blocking certain enzymes in cancer cells, leading to their destruction and preventing tumor growth.
Borzomed is commonly used as part of combination chemotherapy regimens to improve treatment outcomes in patients with blood cancers. This injection is administered by a qualified healthcare professional in a hospital or oncology center.
Storage: Store below 25°C, protect from light and moisture, and keep in original packaging.
Buy Borzomed Bortezomib 3.5 mg Injection | Bortezomib Exporter from India
Borzomed Bortezomib 3.5 mg Injection is widely used for the treatment of multiple myeloma and mantle cell lymphoma. As a powerful proteasome inhibitor, it helps slow the growth of cancer cells and improves patient outcomes when used as part of chemotherapy treatment.
We are a trusted pharmaceutical exporter from India, supplying Borzomed Bortezomib Injection with safe packaging and fast global delivery. We provide high-quality oncology medicines to hospitals, pharmacies, and distributors worldwide.
Our export network covers Australia, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.
Why Choose Us
-
Genuine WHO-GMP certified oncology medicines
-
Competitive global pricing
-
Secure packaging and reliable logistics
-
Fast international shipping
-
Trusted pharmaceutical exporter from India
